Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Clinical trial NCT07543419 · RECRUITING
Trial details
- NCT number
- NCT07543419
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-17
- Primary completion
- 2028-09-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.